Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1996 Apr;80(4):288–291. doi: 10.1136/bjo.80.4.288

Long term results of intraoperative mitomycin C in the treatment of recurrent pterygium.

L Mastropasqua 1, P Carpineto 1, M Ciancaglini 1, P Enrico Gallenga 1
PMCID: PMC505450  PMID: 8703875

Abstract

AIM: The study was designed to evaluate the long term results of intraoperative mitomycin C in patients with one recurrence of pterygium. METHODS: In 45 white patients with one recurrence of pterygium the 'bare sclera technique' was performed and a sterile sponge soaked in a 0.2 mg/ml (0.02%) mitomycin C solution was placed intraoperatively on the sclera for 3 minutes. The control group underwent surgical excision only. Recurrences were analysed by the chi 2 test and the method of Kaplan-Meier (life table analysis); the difference between survival curves was tested by the log rank test. The chi 2 test with Yates's correction or Fisher's exact test were used to analyse the difference in complications and side effects between the two groups. RESULTS: After a mean postoperative follow up of 34.55 (SD 13.70) months, 6 recurrences (12.5%) were observed in the mitomycin C treated patients and 16 (35.6%) in the control patients (p = 0.027). The 24 and 48 month life table success rates were 89% and 83% in the mitomycin C treated group and 66% and 63% in the control group, respectively (p = 0.022). No severe side effects appeared during follow up. Superficial punctate keratitis appeared in the early postoperative period in only seven mitomycin C treated eyes (15.5%) (p = 0.018). CONCLUSION: This study confirms the efficacy of intraoperative mitomycin C in improving the success rate after recurrent pterygium surgical excision.

Full text

PDF
288

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bahrassa F., Datta R. Postoperative beta radiation treatment of pterygium. Int J Radiat Oncol Biol Phys. 1983 May;9(5):679–684. doi: 10.1016/0360-3016(83)90234-1. [DOI] [PubMed] [Google Scholar]
  2. Butrus S. I., Ashraf M. F., Laby D. M., Rabinowitz A. I., Tabbara S. O., Hidayat A. A. Increased numbers of mast cells in pterygia. Am J Ophthalmol. 1995 Feb;119(2):236–237. doi: 10.1016/s0002-9394(14)73882-6. [DOI] [PubMed] [Google Scholar]
  3. Chayakul V. Postoperative mitomycin-C eye drop and beta radiation in the treatment of pterygia. J Med Assoc Thai. 1991 Sep;74(9):373–376. [PubMed] [Google Scholar]
  4. Chayakul V. Prevention of recurrent pterygium by mitomycin-C. Fortschr Ophthalmol. 1987;84(5):422–424. [PubMed] [Google Scholar]
  5. Dunn J. P., Seamone C. D., Ostler H. B., Nickel B. L., Beallo A. Development of scleral ulceration and calcification after pterygium excision and mitomycin therapy. Am J Ophthalmol. 1991 Sep 15;112(3):343–344. doi: 10.1016/s0002-9394(14)76738-8. [DOI] [PubMed] [Google Scholar]
  6. Frucht-Pery J., Ilsar M., Hemo I. Single dosage of mitomycin C for prevention of recurrent pterygium: preliminary report. Cornea. 1994 Sep;13(5):411–413. doi: 10.1097/00003226-199409000-00006. [DOI] [PubMed] [Google Scholar]
  7. Frucht-Pery J., Ilsar M. The use of low-dose mitomycin C for prevention of recurrent pterygium. Ophthalmology. 1994 Apr;101(4):759–762. doi: 10.1016/s0161-6420(94)31269-3. [DOI] [PubMed] [Google Scholar]
  8. Gupta S., Basti S. Corneoscleral, ciliary body, and vitreoretinal toxicity after excessive instillation of mitomycin C. Am J Ophthalmol. 1992 Oct 15;114(4):503–504. doi: 10.1016/s0002-9394(14)71867-7. [DOI] [PubMed] [Google Scholar]
  9. Hayasaka S., Noda S., Yamamoto Y., Setogawa T. Postoperative instillation of low-dose mitomycin C in the treatment of primary pterygium. Am J Ophthalmol. 1988 Dec 15;106(6):715–718. doi: 10.1016/0002-9394(88)90706-4. [DOI] [PubMed] [Google Scholar]
  10. Hayasaka S., Noda S., Yamamoto Y., Setogawa T. Postoperative instillation of mitomycin C in the treatment of recurrent pterygium. Ophthalmic Surg. 1989 Aug;20(8):580–583. [PubMed] [Google Scholar]
  11. Hill J. C., Maske R. Pathogenesis of pterygium. Eye (Lond) 1989;3(Pt 2):218–226. doi: 10.1038/eye.1989.31. [DOI] [PubMed] [Google Scholar]
  12. Hirst L. W., Sebban A., Chant D. Pterygium recurrence time. Ophthalmology. 1994 Apr;101(4):755–758. doi: 10.1016/s0161-6420(94)31270-x. [DOI] [PubMed] [Google Scholar]
  13. Kaimbo K. Traitement chirurgical du ptérygion: 42 cas d'excision. J Fr Ophtalmol. 1988;11(4):335–338. [PubMed] [Google Scholar]
  14. Kloess P. M., Yee R. W., Hopp L. M. Mitomycin C after pterygium excision. Ophthalmology. 1993 Mar;100(3):292–293. doi: 10.1016/s0161-6420(93)38533-7. [DOI] [PubMed] [Google Scholar]
  15. Mahar P. S., Nwokora G. E. Role of mitomycin C in pterygium surgery. Br J Ophthalmol. 1993 Jul;77(7):433–435. doi: 10.1136/bjo.77.7.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mastropasqua L., Carpineto P., Ciancaglini M., Lobefalo L., Gallenga P. E. Effectiveness of intraoperative mitomycin C in the treatment of recurrent pterygium. Ophthalmologica. 1994;208(5):247–249. doi: 10.1159/000310500. [DOI] [PubMed] [Google Scholar]
  17. Rubinfeld R. S., Pfister R. R., Stein R. M., Foster C. S., Martin N. F., Stoleru S., Talley A. R., Speaker M. G. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology. 1992 Nov;99(11):1647–1654. doi: 10.1016/s0161-6420(92)31749-x. [DOI] [PubMed] [Google Scholar]
  18. Sebban A., Hirst L. W. Pterygium recurrence rate at the Princess Alexandra Hospital. Aust N Z J Ophthalmol. 1991 Aug;19(3):203–206. doi: 10.1111/j.1442-9071.1991.tb00661.x. [DOI] [PubMed] [Google Scholar]
  19. Simona F., Anastasi-Forni C., Benedetti C., Failla F. G., Rossi F. M., Meyer U. Le traitment adjonctif par un collyre de mitomycine après excision du ptérygion: l'expérience tessinoise. Klin Monbl Augenheilkd. 1994 May;204(5):409–412. doi: 10.1055/s-2008-1035571. [DOI] [PubMed] [Google Scholar]
  20. Singh G., Wilson M. R., Foster C. S. Long-term follow-up study of mitomycin eye drops as adjunctive treatment of pterygia and its comparison with conjunctival autograft transplantation. Cornea. 1990 Oct;9(4):331–334. [PubMed] [Google Scholar]
  21. Singh G., Wilson M. R., Foster C. S. Mitomycin eye drops as treatment for pterygium. Ophthalmology. 1988 Jun;95(6):813–821. doi: 10.1016/s0161-6420(88)33104-0. [DOI] [PubMed] [Google Scholar]
  22. Spires R. Postoperative instillation of mitomycin eye drops in the treatment of primary pterygium. J Ophthalmic Nurs Technol. 1991 Jan-Feb;10(1):15–17. [PubMed] [Google Scholar]
  23. Sugar A. Who should receive mitomycin-C after pterygium surgery? Ophthalmology. 1992 Nov;99(11):1645–1646. doi: 10.1016/s0161-6420(92)31750-6. [DOI] [PubMed] [Google Scholar]
  24. Yamanouchi U., Mishima K. [Eye lesions due to mitomycin C instillation after pterygium operation]. Nihon Ganka Kiyo. 1967 Aug;18(8):854–861. [PubMed] [Google Scholar]
  25. Youngson R. M. Recurrence of pterygium after excision. Br J Ophthalmol. 1972 Feb;56(2):120–125. doi: 10.1136/bjo.56.2.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. de Keizer R. J. Pterygium excision with or without postoperative irradiation, a double-blind study. Doc Ophthalmol. 1982 Jan 29;52(3-4):309–315. doi: 10.1007/BF01675860. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES